Disease Market Research, Intelligence and Forecasts
In this section you will find information products, including market research, covering disease research, including latest technologies, company profiles, biopharmaceuticals, market data and information covering Europe, the UK, North America and Asia.
Stay up-to-date with new products added to this category »
|
Title
|
Publication Date
|
Price
|
|
World Market for Anti-Infectives (Antifungals, Antibacterials and Antivirals)
|
February 2012 |
£2405 |
|
Triple Analysis: Lymphoma, Angiogenesis and Peptides
|
January 2012 |
£2865 |
|
Triple Analysis: Lymphoma, Pancreatic Cancer and Angiogenesis
|
January 2012 |
£2865 |
|
Triple Analysis: Colorectal Cancer, Lymphoma and Angiogenesis
|
January 2012 |
£2865 |
|
Triple Analysis: Lymphoma, Angiogenesis and Protein Kinase Inhibitors
|
January 2012 |
£2865 |
|
Triple Analysis: Breast Cancer, Lymphoma and Angiogenesis
|
January 2012 |
£2865 |
|
Triple Analysis: Melanoma, Angiogenesis and Antibodies
|
January 2012 |
£2865 |
|
Triple Analysis: Lymphoma, Angiogenesis and Cancer Vaccines
|
January 2012 |
£2865 |
|
Triple Analysis: Lung Cancer, Lymphoma and Angiogenesis
|
January 2012 |
£2865 |
|
Triple Analysis: Leukemia, Lymphoma and Angiogenesis
|
January 2012 |
£2865 |
|
Triple Analysis: Lymphoma, Prostate Cancer and Angiogenesis
|
January 2012 |
£2865 |
|
Triple Analysis: Lymphoma, Apoptosis and Angiogenesis
|
January 2012 |
£2865 |
|
Triple Analysis: Lymphoma, Angiogenesis and Antibodies
|
January 2012 |
£2865 |
|
Triple Analysis: Lymphoma, Melanoma and Angiogenesis
|
January 2012 |
£2865 |
Antifungals Market to 2017
Generic Erosion of Major Polyenes, Azoles, Allylamines and Echinocandins to Slow Value Growth
|
January 2012 |
£2215 |
Atherosclerosis or Coronary Artery Disease (CAD) Therapeutics
Pipeline Assessment and Market Forecasts to 2018
|
January 2012 |
£2215 |
Venous Thromboembolism (VTE) Therapeutics
Pipeline Assessment and Market Forecasts to 2018
|
January 2012 |
£2525 |
Gaucher's Disease Therapeutics
Pipeline Assessment and Market Forecasts to 2018
|
January 2012 |
£2215 |
|
Triple Analysis: Lymphoma, Apoptosis and Peptides
|
December 2011 |
£2865 |
|
Triple Analysis: Breast Cancer, Lymphoma and Apoptosis
|
December 2011 |
£2865 |
Unstable Angina Therapeutics
Pipeline Assessment and Market Forecasts to 2018
|
December 2011 |
£2215 |
Hospital Acquired Bacterial Infections Market to 2017
Niche Players are Most Active in R&D, Positioning Them as Potential Acquisition Targets for Big Pharma
|
December 2011 |
£2215 |
|
Triple Analysis: Lymphoma, Apoptosis and Cancer Vaccines
|
December 2011 |
£2865 |
Peptic Ulcer Therapeutics
Pipeline Assessment and Market Forecasts to 2018
|
December 2011 |
£2215 |
|
Triple Analysis: Lung Cancer, Lymphoma and Apoptosis
|
December 2011 |
£2865 |
|
Triple Analysis: Lymphoma, Apoptosis and Antibodies
|
December 2011 |
£2865 |
|
Triple Analysis: Leukemia, Lymphoma and Apoptosis
|
December 2011 |
£2865 |
|
Triple Analysis: Colorectal Cancer, Lymphoma and Apoptosis
|
December 2011 |
£2865 |
Erectile Dysfunction Therapeutics
Pipeline Assessment and Market Forecasts to 2018
|
December 2011 |
£2215 |
Tuberculosis Infection
Pipeline Assessment and Market Forecasts to 2018
|
December 2011 |
£2215 |
